Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
1.
Chonnam Medical Journal ; : 20-24, 2019.
Article in English | WPRIM | ID: wpr-719480

ABSTRACT

The aim of this study was to compare radioactive iodine (I-131) biokinetics after recombinant human TSH stimulation (rhTSH) and thyroid hormone withdrawal (THW) in patients with differentiated thyroid cancer (DTC). External effective dose rates were measured using external detectors and imaged quantitatively at the time of discharge from the isolation wards. We retrospectively analyzed 32 patients who had been diagnosed with DTC, papillary or follicular, and underwent remnant ablation after either rhTSH stimulation (n=22) or THW (n=10). The uptake of I-131 by remnant thyroid tissue was measured from 20.0 cm, 100.0 cm and 200.0 cm distances using a handheld external detector. The remnant thyroid tissue measured by the whole body images two to five days from administration was 10.7+26.0% (range 0.5 to 60.0%). The values measured at 20 cm were best correlated to the thyroid residual uptake measured by SPECT/CT. The half-lives of I-131washout (T1/2) in rhTSH group measured by external detector were shorter than those of THW group. T1/2 becomes longer when it was measured over longer distances. They were 10.9, 12.3 and 13.1 hours at distances of 20, 100, and 200 cm in rhTSH group, respectively. The TWH group showed 12.8, 14.9 and 17.7 hours, respectively. We conclude that I-131 biokinetics can be measured by external detector after high dose I-131 therapy for DTC. It showed that washout of I-131 was faster after rhTSH stimulation than THW, and slower in patients with distant metastasis than those without metastasis.


Subject(s)
Humans , Body Image , Iodine , Iodine Radioisotopes , Neoplasm Metastasis , Neoplasm, Residual , Retrospective Studies , Thyroid Gland , Thyroid Neoplasms , Thyroidectomy , Thyrotropin Alfa
2.
Asia Oceania Journal of Nuclear Medicine and Biology. 2016; 4 (1): 51-54
in English | IMEMR | ID: emr-176192

ABSTRACT

To the best of our knowledge, imaging of accidental exposure to radioactive fluorine-18 [F-18] due to liquid spill has not been described earlier in the scientific literature. The short half-life of F-18 [t[1/2]=110 min], current radiation safety requirements, and Good Manufacturing Practice [GMP] regulations on radiopharmaceuticals have restrained the occurrence of these incidents. The possibility of investigating this type of incidents by gamma and positron imaging is also quite limited. Additionally, a quick and precise analysis of radiochemical contamination is cumbersome and sometimes challenging if the spills of radioactive materials are low in activity. Herein, we report a case of accidental F-18 contamination in a service person during a routine cyclotron maintenance procedure. During target replacement, liquid F-18 was spilled on the person responsible for the maintenance. The activities of spills were immediately measured using contamination detectors, and the photon spectrum of contaminated clothes was assessed through gamma spectroscopy. Despite protective clothing, some skin areas were contaminated, which were then thoroughly washed. Later on, these areas were imaged, using positron emission tomography [PET], and a gamma camera [including spectroscopy]. Two contaminated skin areas were located on the hand [9.7 and 14.7 cm[2], respectively], which showed very low activities [19.0 and 22.8 kBq respectively at the time of incident]. Based on the photon spectra, F-18 was confirmed as the main present radionuclide. PET imaging demonstrated the shape of these contaminated hot spots. However, the measured activities were very low due to the use of protective clothing. With prompt action and use of proper equipments at the time of incident, minimal radionuclide activities and their locations could be thoroughly analyzed. The cumulative skin doses of the contaminated regions were calculated at 1.52 and 2.00 mSv, respectively. In the follow-up, no skin changes were observed in the contaminated areas


Subject(s)
Humans , Male , Adult , Chemical Hazard Release , Radiation Exposure , Positron-Emission Tomography , Radiopharmaceuticals , Skin , Radionuclide Imaging
SELECTION OF CITATIONS
SEARCH DETAIL